(Q51083517)

English

Development and validation of a short measure of health status for individuals with amyotrophic lateral sclerosis/motor neurone disease: the ALSAQ-40.

scientific article published in November 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/10631656

Development and validation of a short measure of health status for individuals with amyotrophic lateral sclerosis/motor neurone disease: the ALSAQ-40. (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/10631656

motor neuron disease

0 references

amyotrophic lateral sclerosis

0 references

author name string

C Jenkinson

1

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/10631656

R Fitzpatrick

2

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/10631656

C Brennan

3

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/10631656

M Bromberg

4

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/10631656

M Swash

5

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/10631656

publication date

1 November 1999

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/10631656

Journal of Neurology

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/10631656

246 Suppl 3

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/10631656

III16-21

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/10631656

https://scigraph.springernature.com/pub.10.1007/bf03161085

0 references

Health outcome and quality-of-life measurements in amyotrophic lateral sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/10631656

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Psychiatric disorders and medical care utilization among people in the general population who report fatigue

1 reference

https://pubmed.ncbi.nlm.nih.gov/10631656

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

https://pubmed.ncbi.nlm.nih.gov/10631656

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II

1 reference

https://pubmed.ncbi.nlm.nih.gov/10631656

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amyotrophic lateral sclerosis: Part 1. Clinical features, pathology, and ethical issues in management.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10631656

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/10631656

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of health-related quality of life and muscle impairment in individuals with amyotrophic lateral sclerosis using the medical outcome survey and the Tufts Quantitative Neuromuscular Exam.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10631656

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Measurement of health-related quality of life in patients with amyotrophic lateral sclerosis in clinical trials of new therapies

1 reference

https://pubmed.ncbi.nlm.nih.gov/10631656

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/10631656

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF03161085

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/10631656

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/10631656

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51083517&oldid=1390684718"